Cambridge Healthtech Institute’s 2nd Annual
Innate Immunity
August 13, 2025
A critical unmet need exists to understand the complex biology surrounding solid tumors, a challenge we must tackle to unlock the full potential of innate immunity-based therapeutics. At Cambridge Healthtech Institute's 2nd Annual Innate Immunity conference on August 13th, we delve into cutting-edge tools like machine learning, 3D organoids, and spatial profiling, and apply these innovations to advance innate immune responses. By first addressing tumor biology and the tumor microenvironment, we enable breakthroughs in reprogramming the immune-suppressive landscape, targeting innate immune checkpoints, and harnessing the power of NK cells, gamma delta T cells, and macrophages. This conference highlights recent breakthroughs and opportunities to transform innate immunity into a cornerstone of cancer therapy, offering novel strategies for durable and effective treatments. Join us to explore the future of innate immunity through groundbreaking science.
Who should attend: Biotech Founders in IO, Pharma Directors, Principal and Senior Scientists, IO Professors and Post-Docs, Immunologists and Oncologists, Computational Biologists, Regulatory Affairs Specialists, Clinical Trial Managers, and those researching NK cells, gamma delta t cells, CAFs, and/or TAMs, Innate Immunity, the tumor microenvironment, or cell therapy.
Coverage will include, but is not limited to:
- Tools and Models for Transformative Innate Immunity
- ML and data science applications to solid tumors
- In vivo, in vitro, 3D, Organoid, and pre-clinical translatable models
- Spatial profiling
- Novel Strategies Based in a Better Understanding of Solid Tumor Biology
- Breakthroughs and targeting multiple TME components at once in solid tumors
- Cancer-associated fibroblasts (CAFs)
- Tumor neo-vasculature
- Tumor-associated macrophages (TAMs)
- NK cells
- Gamma delta T cells
- Reprogramming the Immune-suppressive landscape
- Cytokines
- Innate immune checkpoints
- Targeting tumor plasticity to enhance innate immune responses
The deadline for priority consideration is January 31, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: